Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia
- PMID: 15632261
- DOI: 10.1093/aje/kwi029
Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia
Abstract
The authors performed a systematic review to summarize the epidemiologic evidence on the association between use of nonsteroidal antiinflammatory drugs (NSAIDs) and the risk of dementia. A total of 25 case-control and cohort studies that reported an odds ratio/relative risk were included. Study-specific log relative risks were weighted by the inverse of their variances to obtain pooled relative risks and 95% confidence intervals. The authors divided the reports into studies with prevalent dementia cases, studies with incident dementia cases, and studies where cognitive decline was used as the clinical endpoint. The pooled relative risks of the three groups of studies were 0.51 (95% confidence interval (CI): 0.37, 0.70), 0.79 (95% CI: 0.68, 0.92), and 1.23 (95% CI: 0.70, 2.31), respectively. Within these subgroups, heterogeneity was present only in the studies with prevalent cases (p = 0.001). Because the benefit of NSAIDs in preventing dementia or cognitive impairment was 50% in studies with prevalent dementia cases, declined to 20% in studies with incident dementia cases, and was absent in studies where cognitive decline was used as the endpoint, the authors conclude that most of the reported beneficial effects of NSAIDs may result from various forms of bias: recall bias, prescription bias, and publication bias.
Similar articles
-
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.N Engl J Med. 2001 Nov 22;345(21):1515-21. doi: 10.1056/NEJMoa010178. N Engl J Med. 2001. PMID: 11794217
-
Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.Ann N Y Acad Sci. 2010 Oct;1207:155-62. doi: 10.1111/j.1749-6632.2010.05726.x. Ann N Y Acad Sci. 2010. PMID: 20955439 Review.
-
Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme.Am J Epidemiol. 2004 Jun 15;159(12):1131-9. doi: 10.1093/aje/kwh153. Am J Epidemiol. 2004. PMID: 15191930
-
The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies.Int J Clin Pract. 2011 Dec;65(12):1295-305. doi: 10.1111/j.1742-1241.2011.02810.x. Int J Clin Pract. 2011. PMID: 22093537 Review.
-
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.J Natl Cancer Inst. 2008 Oct 15;100(20):1439-47. doi: 10.1093/jnci/djn324. Epub 2008 Oct 7. J Natl Cancer Inst. 2008. PMID: 18840819
Cited by
-
L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels.Pharmaceutics. 2020 Apr 11;12(4):344. doi: 10.3390/pharmaceutics12040344. Pharmaceutics. 2020. PMID: 32290494 Free PMC article.
-
Peripheral inflammatory markers in amnestic mild cognitive impairment.Int J Geriatr Psychiatry. 2014 Mar;29(3):221-6. doi: 10.1002/gps.3988. Epub 2013 Jul 15. Int J Geriatr Psychiatry. 2014. PMID: 23857873 Free PMC article.
-
NSAID Use and Incident Cognitive Impairment in a Population-based Cohort.Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):105-12. doi: 10.1097/WAD.0000000000000098. Alzheimer Dis Assoc Disord. 2016. PMID: 26079710 Free PMC article.
-
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing.Pharmaceuticals (Basel). 2022 Jul 3;15(7):827. doi: 10.3390/ph15070827. Pharmaceuticals (Basel). 2022. PMID: 35890126 Free PMC article. Review.
-
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?Front Aging Neurosci. 2010 May 21;2:19. doi: 10.3389/fnagi.2010.00019. eCollection 2010. Front Aging Neurosci. 2010. PMID: 20725517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical